Skip to content

Leveraging eSource for Study Managers

Leveraging eSource for Study Managers

In this white paper, author Takoda Roland, Associate Director of Clinical Operations at Sitero, a forward-thing CRO, discusses the benefits and implementation of eSource as a study manager for remote monitoring in clinical trials. The author highlights his firsthand experience with eSource, specifically using the CRIO platform, and its ability to streamline processes and increase efficiency for study teams.

Benefits of leveraging eSource

Roland emphasizes the efficiency gains achieved through eSource adoption. eSource significantly reduces the workload for research sites by simplifying data entry and providing a step-by-step process for each visit. eSource also minimizes errors and missed procedures through real-time data validation. This leads to improved patient visit times and reduced reliance on traditional monitoring methods.

Standardization of source data is identified as a key advantage of eSource. This ensures critical data points are captured and facilitates cross-site trend analysis.

Other eSource benefits included the ability for doctors to review patients’ charts remotely, reducing their burden and improving efficiency. Some sites even outsource EDC entry to offsite facilities, further enhancing productivity.

Leveraging eSource for Study Managers

While the advantages of eSource are evident for research sites, Roland argues that it offers even greater benefits CROs. The author recounts their efforts to implement remote monitoring leveraging eSource, which became a necessity due to the COVID-19 pandemic. Remote monitoring resulted in improved monitoring metrics, increased pages monitored per day, enhanced patient safety, and greater efficiency for CRAs who were no longer burdened by travel.

The full potential of eSource in transforming clinical trial monitoring is yet to be fully realized. Roland suggests that remote monitoring should become a standard component of every clinical trial. He also emphasizes the need for continued exploration and utilization of eSource in the future. Download the full case study complete insights.

by Takoda Roland Clinical Research Consultant
Share this white paper
You may also find interesting
Explore our White Papers & eBooks
A Comparison of EMR and eSource in Clinical Research Trials

A Comparison of EMR and eSource Data

In a comparison of EMR and eSource data, we analyzed the medications and medical history documented in the EMR versus the EDC of subjects in active ongoing clinical research studies. The goal was to assess the validity of the assumption of the utility of using EMR data directly. The present study reveals a significant data...

An enterprise-grade eClinical solution, CRIO

An Enterprise-Grade eClinical Solution – CRIO

You need a partner that is capable of meeting your enterprise requirements and regulatory obligations. CRIO is an enterprise-grade eClinical solution. This guide describes some of CRIO’s best practices that differentiate us from other vendors. Download the full white paper to explore CRIO, the industry’s #1 site-based eSource solution.  

Electronic Source Reduces Protocol Deviations

eSource Reduces Protocol Deviations Compared to Paper Source

With nine locations in Texas, California and Louisiana, and five-time recipient of the Best Clinical Trials Site/Network award from the World Vaccine Congress, Benchmark Research is one of the industry’s leading vaccine network. This white paper provides an in-depth analysis from three participating Benchmark Research. Specifically, results indicate that using CRIO electronic source (eSource) reduces...